{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26920910", "DateCompleted": {"Year": "2016", "Month": "09", "Day": "19"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "02", "Day": "27"}], "ELocationID": ["84", "10.1186/s12906-016-1047-7"], "Language": ["eng"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "16", "PubDate": {"Year": "2016", "Month": "Feb", "Day": "27"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Effect of Cosmos caudatus (Ulam raja) supplementation in patients with type 2 diabetes: Study protocol for a randomized controlled trial.", "Pagination": {"StartPage": "84", "MedlinePgn": "84"}, "Abstract": {"AbstractText": ["Type 2 diabetes mellitus is a major health threat worldwide. Cosmos caudatus is one of the medicinal plants used to treat type 2 diabetes. Therefore, this study aims to determine the effectiveness and safety of C. caudatus in patients with type 2 diabetes. Metabolomic approach will be carried out to compare the metabolite profiles between C. Caudatus treated diabetic patients and diabetic controls.", "This is a single-center, randomized, controlled, two-arm parallel design clinical trial that will be carried out in a tertiary hospital in Malaysia. In this study, 100 patients diagnosed with type 2 diabetes will be enrolled. Diabetic patients who meet the eligibility criteria will be randomly allocated to two groups, which are diabetic C. caudatus treated(U) group and diabetic control (C) group. Primary and secondary outcomes will be measured at baseline, 4, 8, and 12\u00a0weeks. The serum and urine metabolome of both groups will be examined using proton NMR spectroscopy.", "The study will be the first randomized controlled trial to assess whether C. caudatus can confer beneficial effect in patients with type 2 diabetes. The results of this trial will provide clinical evidence on the effectiveness and safety of C. caudatus in patients with type 2 diabetes.", "ClinicalTrials.gov identifier: NCT02322268."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. shihui0731@gmail.com."}], "LastName": "Cheng", "ForeName": "Shi-Hui", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia."}, {"Identifier": [], "Affiliation": "Research Centre of Excellent for Nutrition and Non-communicable Diseases, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, 43300, Selangor, Malaysia."}], "LastName": "Ismail", "ForeName": "Amin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, 43300, Selangor, Malaysia."}], "LastName": "Anthony", "ForeName": "Joseph", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, 43300, Selangor, Malaysia."}], "LastName": "Ng", "ForeName": "Ooi Chuan", "Initials": "OC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, Serdang, 43300, Selangor, Malaysia."}], "LastName": "Hamid", "ForeName": "Azizah Abdul", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia. bnisak@upm.edu.my."}, {"Identifier": [], "Affiliation": "Research Centre of Excellent for Nutrition and Non-communicable Diseases, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, 43300, Selangor, Malaysia. bnisak@upm.edu.my."}], "LastName": "Yusof", "ForeName": "Barakatun-Nisak Mohd", "Initials": "BN"}], "DataBankList": [{"DataBankName": "ClinicalTrials.gov", "AccessionNumberList": ["NCT02322268"]}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Asteraceae"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood Glucose"}, {"QualifierName": [], "DescriptorName": "Clinical Protocols"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Research Design"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "International Diabetes Federation . IDF Diabetes Atlas. 6. Brussels: International Diabetes Federation; 2013.", "ArticleIdList": ["35914061"]}, {"Citation": "Institute for Public Health . The fourth National Health & Morbidity Survey 2011 (NHMS IV) Kuala Lumpur: National Institutes of Health Malaysia: Ministry of Health; 2011."}, {"Citation": "Mafauzy M, Hussein Z, Chan SP. The status of diabetes control in Malaysia: Results of DiabCare 2008. Med J Malaysia. 2011;66(3):175\u201381.", "ArticleIdList": ["22111435"]}, {"Citation": "Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77\u201382. doi: 10.2337/diaclin.26.2.77.", "ArticleIdList": ["10.2337/diaclin.26.2.77"]}, {"Citation": "Nauck M, Frid A, Hermansen K, Shah NS, Tankova T, Mitha IH, et al. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)- 2 study. Diabetes Care. 2009;32(1):84\u201390. doi: 10.2337/dc08-1355.", "ArticleIdList": ["10.2337/dc08-1355", "PMC2606836", "18931095"]}, {"Citation": "Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care. 2012;35(6):1364\u201379. doi: 10.2337/dc12-0413.", "ArticleIdList": ["10.2337/dc12-0413", "PMC3357214", "22517736"]}, {"Citation": "Ball AJ, Flatt PR, McClenaghan NH. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide. Eur J Pharmacol. 2000;408(3):327\u201333. doi: 10.1016/S0014-2999(00)00782-2.", "ArticleIdList": ["10.1016/S0014-2999(00)00782-2", "11090651"]}, {"Citation": "Van Raalte DH, Diamant M. Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res Clin Pract. 2011;93(Suppl 1):S37\u201346. doi: 10.1016/S0168-8227(11)70012-2.", "ArticleIdList": ["10.1016/S0168-8227(11)70012-2", "21864750"]}, {"Citation": "Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9(4):301\u201314. doi: 10.1007/s11154-008-9104-2.", "ArticleIdList": ["10.1007/s11154-008-9104-2", "PMC4239697", "18709457"]}, {"Citation": "Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058\u201370. doi: 10.1161/CIRCRESAHA.110.223545.", "ArticleIdList": ["10.1161/CIRCRESAHA.110.223545", "PMC2996922", "21030723"]}, {"Citation": "Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res. 2008;638(1\u20132):98\u2013102. doi: 10.1016/j.mrfmmm.2007.09.002.", "ArticleIdList": ["10.1016/j.mrfmmm.2007.09.002", "17964614"]}, {"Citation": "Kuppusamy UR, Indran M, Rokiah P. Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients. Diabet Med. 2005;22(10):1343\u20136. doi: 10.1111/j.1464-5491.2005.01630.x.", "ArticleIdList": ["10.1111/j.1464-5491.2005.01630.x", "16176194"]}, {"Citation": "Styskal J, Van Remmen H, Richardson A, Salmon AB. Oxidative stress and diabetes: What can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic Biol Med. 2012;52(1):46\u201358. doi: 10.1016/j.freeradbiomed.2011.10.441.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.10.441", "PMC3249484", "22056908"]}, {"Citation": "Surya S, Salam AD, Tomy DV, Carla B, Kumar RA, Sunil C. Diabetes mellitus and medicinal plants-a review. Asian Pac J Trop Dis. 2014;4(5):337\u201347. doi: 10.1016/S2222-1808(14)60585-5.", "ArticleIdList": ["10.1016/S2222-1808(14)60585-5"]}, {"Citation": "Bailey CJ, Campbell IW, Chan JCN, Davidson JA, Howlett HCS, Ritz P. Metformin- the Gold Standard: A Scientific handbook. Chichester: Wiley; 2007."}, {"Citation": "Cheng S-H, Barakatun-Nisak MY, Anthony J, Ismail A. Potential medicinal benefits of Cosmos caudatus (Ulam Raja): A scoping review. J Res Med Sci. 2015;20:1000\u20136. doi: 10.4103/1735-1995.168406.", "ArticleIdList": ["10.4103/1735-1995.168406", "PMC4746859", "26929767"]}, {"Citation": "Sekar M, Zulhilmi M, Hamdi AY, Nabila N, Zahida Z, Shafiq M. Ten commonly available medicinal plants in Malaysia used for the treatment of diabetes-a review. Asian J Pharm Clin Res. 2014;7(1):1\u20135."}, {"Citation": "Abas F, Shaari K, Lajis NH, Israf DA, Kalsom YU. Antioxidative and radical scavenging properties of the constituents isolated from Cosmos caudatus Kunth. Nat Prod Res. 2003;9(4):245\u20138."}, {"Citation": "Mustafa RA, Abdul HA, Mohamed S, Bakar FA. Total phenolic compounds, flavonoids, and radical scavenging activity of 21 selected tropical plants. J Food Sci. 2010;75(1):C28\u201335. doi: 10.1111/j.1750-3841.2009.01401.x.", "ArticleIdList": ["10.1111/j.1750-3841.2009.01401.x", "20492146"]}, {"Citation": "Shui GH, Leong LP, Wong SP. Rapid screening and characterization of antioxidants of Cosmos caudatus using liquid chromatography coupled with mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827(1):127\u201338. doi: 10.1016/j.jchromb.2005.07.029.", "ArticleIdList": ["10.1016/j.jchromb.2005.07.029", "16087413"]}, {"Citation": "Sukrasno, Fidriany I, Anggadiredja K, Handayani WA, Anam K. Influence of drying method on flavonoid content of Cosmos caudatus (kunth) leaves. Res J Med Plant. 2011;5(2):189\u201395. doi: 10.3923/rjmp.2011.189.195.", "ArticleIdList": ["10.3923/rjmp.2011.189.195"]}, {"Citation": "Leong LP, Shui G. An investigation of antioxidant capacity of fruits in Singapore markets. Food Chem. 2002;76(1):69\u201375. doi: 10.1016/S0308-8146(01)00251-5.", "ArticleIdList": ["10.1016/S0308-8146(01)00251-5"]}, {"Citation": "Perumal V, Hamid AA, Ismail A, Saari K, Abas F. Effect of Cosmos caudatus Kunth leaves on the lipid profile of a hyperlipidemia-induced animal model. J Food Chem Nutr. 2014;2(1):43\u201351."}, {"Citation": "Amalia L, Anggadiredja K, Sukrasno, Fidrianny I, Inggraini R. Antihypertensive potency of wild Cosmos (Cosmos caudatus Kunth, Asteraceae) leaf extract. J Pharmacol Toxicol. 2012;7(8):359\u201368. doi: 10.3923/jpt.2012.359.368.", "ArticleIdList": ["10.3923/jpt.2012.359.368"]}, {"Citation": "Ajaykumar TV, Anandarajagopal K, Sunilson JAJ, Arshad A, Jainaf RAM, Venkateshan N. Anti-inflammatory activity of Cosmos Caudatus. Int J Univers Pharm Bio Sci. 2012;1(2):40\u20138."}, {"Citation": "Zhang A, Qiu S, Xu H, Sun H, Wang X. Metabolomics in diabetes. Clin Chim Acta. 2014;429:106\u201310. doi: 10.1016/j.cca.2013.11.037.", "ArticleIdList": ["10.1016/j.cca.2013.11.037", "24321733"]}, {"Citation": "Friedrich N. Metabolomics in diabetes research. J Endocrinol. 2012;215(1):29\u201342. doi: 10.1530/JOE-12-0120.", "ArticleIdList": ["10.1530/JOE-12-0120", "22718433"]}, {"Citation": "Brennan L. Progress in Nuclear Magnetic Resonance Spectroscopy NMR-based metabolomics : From sample preparation to applications in nutrition research. Prog Nucl Magn Reson Spectrosc. 2014;83:42\u20139. doi: 10.1016/j.pnmrs.2014.09.001.", "ArticleIdList": ["10.1016/j.pnmrs.2014.09.001", "25456316"]}, {"Citation": "Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med. 2009;22(5):507\u201312. doi: 10.3122/jabfm.2009.05.080093.", "ArticleIdList": ["10.3122/jabfm.2009.05.080093", "19734396"]}, {"Citation": "WHO . Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: World Health Organization; 1997.", "ArticleIdList": ["11234459"]}, {"Citation": "Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids. 1987;45(2-4):337\u201351. doi: 10.1016/0009-3084(87)90071-5.", "ArticleIdList": ["10.1016/0009-3084(87)90071-5", "3319232"]}, {"Citation": "Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395. doi: 10.1249/01.MSS.0000078924.61453.FB.", "ArticleIdList": ["10.1249/01.MSS.0000078924.61453.FB", "12900694"]}, {"Citation": "Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med. 2010;152(11):726\u2013732. doi: 10.7326/0003-4819-152-11-201006010-00232.", "ArticleIdList": ["10.7326/0003-4819-152-11-201006010-00232", "20335313"]}, {"Citation": "Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2006;27(1):1\u201393. doi: 10.1016/j.mam.2005.07.008.", "ArticleIdList": ["10.1016/j.mam.2005.07.008", "16105678"]}, {"Citation": "Smolinska A, Blanchet L, Buydens LMC, Wijmenga SS. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta. 2012;750:82\u201397. doi: 10.1016/j.aca.2012.05.049.", "ArticleIdList": ["10.1016/j.aca.2012.05.049", "23062430"]}, {"Citation": "Griffin JL, Atherton H, Shockcor J, Atzori L. Metabolomics as a tool for cardiac research. Nat Rev Cardiol. 2011;8(11):630\u201343. doi: 10.1038/nrcardio.2011.138.", "ArticleIdList": ["10.1038/nrcardio.2011.138", "21931361"]}, {"Citation": "Duarte IF, Diaz SO, Gil AM. NMR metabolomics of human blood and urine in disease research. J Pharm Biomed Anal. 2014;93:17\u201326. doi: 10.1016/j.jpba.2013.09.025.", "ArticleIdList": ["10.1016/j.jpba.2013.09.025", "24854435"]}, {"Citation": "Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, et al. The human serum metabolome. PLoS One. 2011;6(2):e16957. doi: 10.1371/journal.pone.0016957.", "ArticleIdList": ["10.1371/journal.pone.0016957", "PMC3040193", "21359215"]}, {"Citation": "Savorani F, Rasmussen MA, Mikkelsen MS, Engelsen SB. A primer to nutritional metabolomics by NMR spectroscopy and chemometrics. Food Res Int. 2013;54(1):1131\u201345. doi: 10.1016/j.foodres.2012.12.025.", "ArticleIdList": ["10.1016/j.foodres.2012.12.025"]}, {"Citation": "Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2014;2(1):65\u201375. doi: 10.1016/S2213-8587(13)70143-8.", "ArticleIdList": ["10.1016/S2213-8587(13)70143-8", "24622670"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "11", "Day": "5"}, {"Year": "2016", "Month": "2", "Day": "12"}, {"Year": "2016", "Month": "2", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "2", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "9", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "2", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["26920910", "PMC4769500", "10.1186/s12906-016-1047-7", "10.1186/s12906-016-1047-7"]}}], "PubmedBookArticle": []}